Customized Oligonucleotide Microarray Gene Expression–Based Classification of Neuroblastoma Patients Outperforms Current Clinical Risk Stratification

Abstract

Integration of gene expression-based class prediction of neuroblastoma patients may improve risk estimation of current neuroblastoma trials.